Mimedx Group, Inc.
MDXG- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001376339
No open-market purchases or sales by Mimedx Group, Inc. insiders were filed in the last 90 days; 227 institutions reported holding it in 13F filings for Q2 2026, worth $430.8M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Mimedx Group, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 194
- −6 vs. Q2 2024
- Shares held
- 98.1M
- +12.6M (+14.7%) vs. Q2 2024
- Total value
- $579.9M
- −$13.0M (−2.2%) vs. Q2 2024
- New holders
- 22
- 59 more added
- Sold out
- 28
- 63 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDXG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 227 | $430.8M |
| Q1 2026 | 239 | $446.3M |
| Q4 2025 | 234 | $724.5M |
| Q3 2025 | 232 | $730.5M |
| Q2 2025 | 223 | $637.0M |
| Q1 2025 | 218 | $774.2M |
| Q4 2024 | 213 | $973.4M |
| Q3 2024 | 194 | $579.9M |
| Q2 2024 | 202 | $657.4M |
| Q1 2024 | 202 | $720.6M |
| Q4 2023 | 200 | $772.5M |
| Q3 2023 | 186 | $414.7M |
| Q2 2023 | 177 | $337.0M |
| Q1 2023 | 164 | $233.7M |
| Q4 2022 | 152 | $184.1M |
| Q3 2022 | 144 | $184.7M |
| Q2 2022 | 153 | $213.7M |
| Q1 2022 | 150 | $289.9M |
| Q4 2021 | 152 | $359.8M |
| Q3 2021 | 142 | $339.3M |
| Q2 2021 | 138 | $712.4M |
| Q1 2021 | 112 | $487.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Mimedx Group, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jump Financial, LLC | 0 | $0 | 0.00% | −80,271−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −73,562−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −34,328−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −29,800−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −26,465−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −17,472−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −14,916−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Custom Index Systems, LLC | 0 | $0 | 0.00% | −11,659−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −11,620−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −11,010−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −10,519−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −10,365−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −10,095−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −10,067−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −5,800−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −1,035−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −786−100.0% | Sold out |
| Signature Resources Capital Management, LLC | 0 | $0 | 0.00% | −695−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| JJJ Advisors Inc. | – | – | – | – | Not filed |